Cargando…

Proteome-Wide Differential Effects of Peritoneal Dialysis Fluid Properties in an In Vitro Human Endothelial Cell Model

To replace kidney function, peritoneal dialysis (PD) utilizes hyperosmotic PD fluids with specific physico-chemical properties. Their composition induces progressive damage of the peritoneum, leading to vasculopathies, decline of membrane function, and PD technique failure. Clinically used PD fluids...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sacnun, Juan Manuel, Hoogenboom, Robin, Eibensteiner, Fabian, Sobieszek, Isabel J., Unterwurzacher, Markus, Wagner, Anja, Herzog, Rebecca, Kratochwill, Klaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317527/ https://www.ncbi.nlm.nih.gov/pubmed/35887356 http://dx.doi.org/10.3390/ijms23148010

Ejemplares similares

Peritoneal Dialysis Fluid Supplementation with Alanyl-Glutamine Attenuates Conventional Dialysis Fluid-Mediated Endothelial Cell Injury by Restoring Perturbed Cytoprotective Responses
por: Herzog, Rebecca, et al.
Publicado: (2020)

In-Depth Analysis of the Extracorporeal Proteome Adsorbed to Dialysis Membranes during Hemodialysis
por: Daniel-Fischer, Lisa, et al.
Publicado: (2022)

The Peritoneal Surface Proteome in a Model of Chronic Peritoneal Dialysis Reveals Mechanisms of Membrane Damage and Preservation
por: Boehm, Michael, et al.
Publicado: (2019)

Assessing mechanical catheter dysfunction in automated tidal peritoneal dialysis using cycler software: a case control, proof-of-concept study
por: Oviedo Flores, Krystell, et al.
Publicado: (2022)

Publisher Correction: Assessing mechanical catheter dysfunction in automated tidal peritoneal dialysis using cycler software: a case control, proof-of-concept study
por: Flores, Krystell Oviedo, et al.
Publicado: (2022)

Understanding Cell Model Characteristics—RNA Expression Profiling in Primary and Immortalized Human Mesothelial Cells, and in Human Vein and Microvascular Endothelial Cells
por: Marinovic, Iva, et al.
Publicado: (2022)

Effects of Alanyl-Glutamine Treatment on the Peritoneal Dialysis Effluent Proteome Reveal Pathomechanism-Associated Molecular Signatures
por: Herzog, Rebecca, et al.
Publicado: (2018)

Targeted Metabolomic Profiling of Peritoneal Dialysis Effluents Shows Anti-oxidative Capacity of Alanyl-Glutamine
por: Wiesenhofer, Florian M., et al.
Publicado: (2019)

A Meta-Analysis of Human Transcriptomics Data in the Context of Peritoneal Dialysis Identifies Novel Receptor-Ligand Interactions as Potential Therapeutic Targets
por: Evgeniou, Michail, et al.
Publicado: (2021)

Functional and Transcriptomic Characterization of Peritoneal Immune-Modulation by Addition of Alanyl-Glutamine to Dialysis Fluid
por: Herzog, Rebecca, et al.
Publicado: (2017)

Cross-Omics Comparison of Stress Responses in Mesothelial Cells Exposed to Heat- versus Filter-Sterilized Peritoneal Dialysis Fluids
por: Kratochwill, Klaus, et al.
Publicado: (2015)

Vibrational Spectroscopy of Peritoneal Dialysis Effluent for Rapid Assessment of Patient Characteristics
por: Grunert, Tom, et al.
Publicado: (2020)

The Extracorporeal Proteome—The Significance of Selective Protein Removal During Dialysis Therapy
por: Kratochwill, Klaus
Publicado: (2018)

Addition of Alanyl-Glutamine to Dialysis Fluid Restores Peritoneal Cellular Stress Responses – A First-In-Man Trial
por: Kratochwill, Klaus, et al.
Publicado: (2016)

Alanyl-Glutamine Restores Tight Junction Organization after Disruption by a Conventional Peritoneal Dialysis Fluid
por: Bartosova, Maria, et al.
Publicado: (2020)

Senescence-Associated Changes in Proteome and O-GlcNAcylation Pattern in Human Peritoneal Mesothelial Cells
por: Herzog, Rebecca, et al.
Publicado: (2015)

Proteomic Research in Peritoneal Dialysis
por: Bonomini, Mario, et al.
Publicado: (2020)

Effect of peritoneal dialysis fluid containing osmo-metabolic agents on human endothelial cells
por: Bonomini, Mario, et al.
Publicado: (2016)

Biocompatible Peritoneal Dialysis Fluids: Clinical Outcomes
por: Cho, Yeoungjee, et al.
Publicado: (2012)

Is there such a thing as biocompatible peritoneal dialysis fluid?
por: Schmitt, Claus Peter, et al.
Publicado: (2016)

Peritoneal Fluid Transport rather than Peritoneal Solute Transport Associates with Dialysis Vintage and Age of Peritoneal Dialysis Patients
por: Waniewski, Jacek, et al.
Publicado: (2016)

Peritoneal dialysis fluid biocompatibility impact on human peritoneal membrane permeability
por: Rodríguez-Esparragón, Francisco, et al.
Publicado: (2018)

Proteomics and peritoneal dialysis: early days but clear potential*
por: Brewis, Ian A., et al.
Publicado: (2010)

Cytotoxic Glucose Degradation Products in Fluids for Peritoneal Dialysis
por: Adib, Noushin, et al.
Publicado: (2011)

Compatibility of aztreonam in four commercial peritoneal dialysis fluids
por: Tobudic, Selma, et al.
Publicado: (2020)

Obesity, Weight Gain, and Fluid Overload in Peritoneal Dialysis
por: Ng, Jack Kit-Chung, et al.
Publicado: (2022)

Characterization and proteomic profile of extracellular vesicles from peritoneal dialysis efflux
por: Carreras-Planella, Laura, et al.
Publicado: (2017)

Optimal peritoneal fluid white blood cell count for diagnosis of peritonitis in peritoneal dialysis patients
por: Kunin, Margarita, et al.
Publicado: (2023)

Bioincompatible Impact of Different Peritoneal Dialysis Fluid Components and Therapeutic Interventions as Tested in a Rat Peritoneal Dialysis Model
por: Stavenuiter, Andrea W. D., et al.
Publicado: (2011)

Aliskiren Prevents the Toxic Effects of Peritoneal Dialysis Fluids during Chronic Dialysis in Rats
por: Pérez-Martínez, Juan, et al.
Publicado: (2012)

Comparison of Longitudinal Membrane Function in Peritoneal Dialysis Patients According to Dialysis Fluid Biocompatibility
por: van Diepen, A.T.N., et al.
Publicado: (2020)

Selective Blocking of TNF Receptor 1 Attenuates Peritoneal Dialysis Fluid Induced Inflammation of the Peritoneum in Mice
por: Kälble, Florian, et al.
Publicado: (2016)

Effect of Benfotiamine in Podocyte Damage Induced by Peritoneal Dialysis Fluid
por: Müller-Krebs, Sandra, et al.
Publicado: (2015)

Steviol glycosides as an alternative osmotic agent for peritoneal dialysis fluid
por: Kopytina, Valeria, et al.
Publicado: (2022)

Hyperglycolysis in endothelial cells drives endothelial injury and microvascular alterations in peritoneal dialysis
por: Si, Zekun, et al.
Publicado: (2023)

The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients
por: Ye, Hongjian, et al.
Publicado: (2017)

Deciphering the Contribution of Biofilm to the Pathogenesis of Peritoneal Dialysis Infections: Characterization and Microbial Behaviour on Dialysis Fluids
por: Sampaio, Joana, et al.
Publicado: (2016)

Ongoing Exposure to Peritoneal Dialysis Fluid Alters Resident Peritoneal Macrophage Phenotype and Activation Propensity
por: Sutherland, Tara E., et al.
Publicado: (2021)

Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis
por: Alvarez Nadal, Marta, et al.
Publicado: (2020)

Peritoneal Dialysis
por: Pyper, R. A.
Publicado: (1948)

Cannot write session to /tmp/vufind_sessions/sess_t0lee5rp08p65ftd8g8gbpcjpt